Surgery alone improves survival in stage 2a/2b neuroblastoma

04/26/2012 | PhysiciansBriefing.com

Patients with low-risk asymptomatic stage 2a or 2b neuroblastoma who were treated with surgery alone had high five-year event-free and overall survival rates, Canadian researchers wrote in the Journal of Clinical Oncology. They assessed outcomes of 915 patients younger than 22 years and found that only 11.1% of them experienced disease recurrence or progression following surgery.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR